🔗 Share this article

An underground market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to contact these profiles directly for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where communities with numerous of members share comparison photos, injection guides and assertions of rapid UK delivery. Sellers promote the drug there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed medication in the UK is worrisome and could result in individuals injecting substances of uncertain source.

Several professionals stated the demand for retatrutide could be connected to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.

Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Material Removal

According to TikTok, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The company stated it was dedicated to keeping the platform safe and allocating resources in strengthening compliance measures.

Online Marketplace Operations

Investigations also found communities with up to 9,000 members marketing retatrutide using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly displays groups with numerous of users, filled with photos of weight loss, positive reviews and detailed instructions for mixing or administering at home.

After moments of joining one group, a seller posted WhatsApp details, where most transactions occur. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.

Product Information and Costs

Within these communities, posts display black plastic parcels with postal service labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20mg. When questioned how much time a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for Telegram said it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering substances they cannot confirm. Although the science behind this drug is valid, these online products may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her team has previously encountered patients injured by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly investigational product not yet authorized … may expose patients to potentially significant medical dangers”.